Delivery Order SPE2DE21D0017-SPE2D625F8NG5
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on August 7, 2025, for ID NOW flu diagnostic testing products. The contract, which carries no set-aside designation, indicates open competition and is scheduled for ultimate completion on August 14, 2025. Performance will occur at the vendor's location in Lockhart, Florida. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $2,208.00 fixed-price with economic price adjustment delivery order is for the ID NOW FLU product, which is a medical diagnostic testing device. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 25, 2025. This award is not associated with a set-aside designation. Abbott Rapid DX North...
- The U.S. federal government awarded a $7,200.00 fixed-price delivery order contract with economic price adjustment to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide 4565764771 ! ID NOW FLU medical supplies. The contract, which does not have a set-aside designation, supports the Defense Logistics Agency Troop Support Medical and is set to be completed by September 16, 2024. Abbott Rapid DX North America LLC, a for-profit organization, is a major supplier of...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain unit to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide the ID NOW FLU testing system. The $43,200.00 fixed-price contract with economic price adjustment has an ultimate completion date of October 31, 2024. The award does not have a set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a major supplier of COVID-19...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,360 fixed-price delivery order with economic price adjustment on July 22, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a Kit ID NOW Strip A2 Qual Detect Mobile Test delivery order, is scheduled for ultimate completion on July 23, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating full and open...
- This federal contract award, valued at $2,880.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical unit to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is a delivery order under the broader DLA Troop Support Medical program and supplies the agency with 4565890608 ID NOW FLU products, which are likely diagnostic COVID-19 testing kits or related medical supplies. The contract is structured as a fixed-price award with economic price...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- This federal contract award, valued at $56,160.00, was issued by the Medical Supply Chain component of the Defense Logistics Agency (DLA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories that specializes in medical diagnostic equipment and testing supplies. The contract is a delivery order for the supply of "4566443576 ! ID NOW FLU" and does not have a set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a...
- This federal contract award, SPE2DE21D0017|SPE2D625F82SJ, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $10,944.00 fixed-price delivery order with economic price adjustment is for the provision of the ID NOW FLU diagnostic product, which is not designated as a set-aside requirement. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic equipment,...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F8NG5Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $10,200 delivery order on July 24, 2025, for ID NOW flu tests under contract 4568885102. This fixed-price delivery order with economic price adjustment has an ultimate completion date of July 31, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding agency is the Defense Logistics Agency (DLA) Medical Supply Chain, which supports federal healthcare testing and diagnostic requirements across defense and military healthcare facilities. This delivery order represents a task order against Abbott Rapid DX's established contract vehicles with the DLA Medical Supply Chain. The company has consistently provided point-of-care diagnostic products to federal agencies, with a particular focus on rapid testing solutions for disease detection. The short performance window through July 2025 and the specific focus on influenza testing aligns with the company's core capabilities in supplying diagnostic test kits to federal healthcare systems, complementing its existing portfolio of COVID-19 and strep testing products delivered through similar procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 7/24/25 |